LINCOCIN SOLUBLE POWDER

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

LINCOMYCIN (AS LINCOMYCIN HYDROCHLORIDE PH. EUR.)

Available from:

Zoetis Belgium S.A.

ATC code:

QJ01FF02

INN (International Name):

LINCOMYCIN (AS LINCOMYCIN HYDROCHLORIDE PH. EUR.)

Dosage:

400 mg/g

Pharmaceutical form:

Powder for Oral Solution

Prescription type:

POM

Therapeutic group:

Porcine

Therapeutic area:

Lincomycin

Therapeutic indications:

Antibacterial

Authorization status:

Authorised

Authorization date:

2017-04-28

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Lincocin Soluble Powder
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Powder for oral solution.
White to off-white free-flowing powder.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of swine dysentery.
4.3 CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to active
ingredient.
Do not treat animals with lincomycin and erythromycin concurrently.
Do not administer to rabbits, hamsters, guinea pigs, chinchillas,
horses or ruminants as this could result in severe gastro-
intestinal disturbance.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None known.
Each gram contains:
Active substance:
Lincomycin
400 mg
(as lincomycin hydrochloride)
For a full list of excipients see section 6.1.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_8_
_/_
_0_
_4_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_5_
_3_
_6_
_5_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTION(S) FOR USE IN ANIMALS:
Avoid inhaling dust and contact with skin.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS:
Avoid skin contact and inhalation of dust.
Wash hands and exposed skin after use.
Persons known to be hypersensitive to the active ingredient should
handle the product with care.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIO